MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Aveooncology.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Aveooncology.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Aveooncology.com most likely does not offer any adult content.
Popular pages
-
Aveo Oncology | An LG Chem company
Click Here To View Our ASCO Poster: TIVO-3: Final OS Analysis Of A Phase III, Randomized, Controlled, Multicenter, Open-Label Study To Compare Tivozanib To Sorafenib In Subjects With Metastatic Renal...
-
Corporate Overview | Aveo Oncology
get_sidebar(); ?> We are united in our efforts to provide patients with reasons to believe that they can receive effective treatments while carrying on with their daily living. AVEO is an oncolog...
-
Pipeline | Aveo Oncology
**Partnered with Bristol Myers Squibb ***Partnered with AstraZeneca AVEO Oncology is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a bet...
-
Press Releases | Aveo Oncology
September 16, 2024 Download PDF – TiNivo-2 FOTIVDA® (tivozanib) monotherapy (control arm) results provide clinically meaningful efficacy and safety data following front-line immune checkpoint inhibito...
-
Our Medicine | Aveo Oncology
get_sidebar(); ?> Approved by the U.S. Food and Drug Administration for the treatment of adults patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prio...
-
Tivozanib | Aveo Oncology
FOTIVDA ® (tivozanib) is an oral, once-daily, next-generation vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI). It is a potent, selective inhibitor of VEGFRs 1, 2, a...